Cancer cell reprogramming: Stem cell differentiation stage factors and an agent based model to optimize cancer treatment

Current Pharmaceutical Biotechnology

Volumn 12, Issue 2, 2011, Pages 231-242

  Biava, P M ^a   Basevi, M ^b   Biggiero, L ^b   Borgonovo, A ^c   Borgonovo, E ^c   Burigana, F ^d  

^a IRCCS MULTIMEDICA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c BOCCONI UNIVERSITY   (Italy)

^d AMEC FOSTER WHEELER   (United States)

Author keywords

Agent based modeling; Cancer stem cells; Computational methods in biology; Simulation; Stem cell differentiation stage factors; Stem cells

Indexed keywords

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; GENE EXPRESSION; HUMAN; LEWIS CARCINOMA; MALIGNANT TRANSFORMATION; PLURIPOTENT STEM CELL; STEM CELL;

EID: 79551651833     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111794295783     Document Type: Article

References (132)

1. Einhorn, L. Are there factors preventing cancer development during embryonic life? Oncodev. Biol. Med., 1982, 4, 219-229.
2. Lakshmi, M. S.; Sherbet, G. V. Embryonic and tumor cell interactions. Karger Basel, 1974, 380-399.
3. Brent, R. L. Radiation teratogenesis. Teratology, 1980, 21, 281-298.
4. Pierce, G.B. The cancer cell and its control by the embryo. Am. J. Pathol., 1983, 113, 116-124.
5. Yu, C-L.; Tsai, M. H. Fetal fetuin selectively induces apoptosis in cancer cell lines and shows anti-cancer activity in tumor animal models. Cancer Lett., 2001, 166, 173-184.
6. Brinster, R. L. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med., 1974, 140, 1049-1056.
7. Minz, B.; Illmensee, K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA, 1975, 72, 3585-3589.
8. Papaioannou, V. E.; McBurney, M. V.; Gardner, R. L.; Evans, R. L. Fate of teratocarcinoma cells injected into early mouse embryos. Nature, 1975, 258, 70-73.
9. Pierce, G. B.; Lewis, S. H.; Miller, G. J.; Moritz, E.; Miller, P. Tumorigenicity of embryonal carcinoma as an essay to study control of malignancy by the murine blastocyst. Proc. Natl. Acad. Sci. USA, 1979, 76, 6649-6651.
10. Pierce, G. B.; Podesta, A.; Wells, R. S. In: Teratocarcinoma Stem Cells- The Role of The Blastocyst Trophoderm in Control of Colony Formation; Silver, S.; Strickland, S.; Martins, G., Ed.; Cold Spring Harbor Laboratory: N.Y., 1983, 10, pp. 15-22.
11. Gershenson, M.; Graves, K.; Carson, S. D.; Wells, R. S.; Pierce, G. B. Regulation of melanoma by the embryonic skin. Proc. Natl. Acad. Sci. USA, 1986, 83, 7307-7310.
12. Pierce, G. B.; Pantazis, C. G.; Caldwell, J. E.; Wells, R. S. Specificity of the control of tumor formation by blastocyst. Cancer Res., 1982, 42, 1082-1087.
13. Webb, C. W.; Gootwine, E.; Sachs, L. Developmental potential of myeloid leukemia cells injected into rat midgestation embryos. Dev. Biol., 1984, 101, 221-224.
14. Weaver, V.; Petersen, O.; Wang, F.; Larabell C.; Briand, P.; Damsky, C.; Bissel, M. Reversion of the malignant phenotype of human breast cancer in three-dimensional culture and in vivo by integrin bloking bodies. J. Cell. Biol., 1997, 137, 231-245.
15. Coleman, W. B.; Wennerberg, A. E.; Smith, G. J.; Grishman, J. W. Regulation of differentiation of diploid and some aneuploid rat liver epithelial(stemlike) cells by the hepatic microenvironment. Am. J. Pathol., 1993, 142, 1373-1382.
16. Postovit, L. M.; Maragaryan, N. V.; Seftor, E. A. Human embryonic stem cell microenvironment suppress the tumorigenic phenotype of aggressive cancer cells. Proc. Natl. Acad. Sci. USA, 2008, 18, 105-111.
17. Lee, M. L.; Seftor, E. A.; Bonde, G.; Cornell, R. A.; Hendrix, M. J. The fate of human malignant melanoma cells transplanted into Zebrafish embryos, assessment of migration and cell division in the absence of tumor formation. Dev. Dyn., 2005, 200 (4), 1560-1570.
18. Topczewska, J. M.; Postovit, L. M.; Margaryan, N.V. Embryonic and tumorogenic pathways converge via Nodal signaling, role in melanoma aggressiveness. Nat. Med., 2006, 12 (8), 925-932.
19. Hendrix, M. J.; Seftor, E. A.; Seftor, R. E. B.; Kaisermeier-Kulesa, J.; Kulesa, P. M.; Postovit, L. M. Reprogramming metastatic tumor cells with embryonic microenvironment. Nat. Rev. Cancer., 2007, 7, 246-255.
20. Kulesa, P. M.; Kasermeier-Kulesa, J. C.; Teddy, J. M.; Margaryan, N. V.; Seftor, E. A.; Hendrix, M. J. Reprogramming metastatic tumor cells to assume a neural crest like phenotype in a embryonic microenvironment. Proc. Natl. Acad. Sci. USA, 2006, 103, 3752-3757.
21. Wells, R. S.; Miotto, K. A. Widespread inhibition of neuroblastoma cells in the 13-to 17-day old mouse embryo. Cancer Res., 1986, 46, 1659-1662.
22. Podesta, A N.; Mullins, J.; Pierce, G. B.; Sell, R. S. The nerula state mouse embryos in control of neuroblastoma. Proc. Natl. Acad. Sci. USA, 1984, 81, 7608-7611.
23. McKinnel, R. G.; Deggins, B. A.; Labat, D. D. Transplantation of pluripotential nuclei from triploid frog tumors. Science, 1969, (165), 394-396.
24. Li, L.; Connelly, M. C.; Wetmore, C.; Currant, T.; Morgan, J. I. Mouse embryos cloned from brain tumors. Cancer Res., 2003, 63, 2733-2737.
25. Gootwine, E.; Webb, C. G.; Sachs, L. Participation of myeloid leukemia cells injected into embryos in haematopoietic differentiation in adult mice. Nature, 1982, 299, 63-65.
26. Biava, P. M.; Fiorito, A.; Negro, C.; Mariani, M. Effect of treatment with embryonic and uterine tissue homogenates on Lewis lung carcinoma development. Cancer Lett., 1988, 41, 265-270.
27. Biava, P. M.; Bonsignorio, D.; Hoxa, M. Life-Protecting Factor (LPF), an anti-cancer low molecular weight fraction isolated from pregnant uterine mucosa during embryo organogenesis. J. Tumor Marker Oncol., 2000, 15(4), 223-233.
28. Biava, P. M.; Bonsignorio, D.; Hoxha, M. Impagliazzo, M.; Frosi, A.; Larese, F.; Negro, C. Mother-embryo cross-talk, the anti-cancer substances produced by mother and embryo during cell differentiation. A review of experimental data. J. Tumor Marker Oncol., 2002, 17 (3), 55-58.
29. Dalerba, P.; Cho, R.W.; Clarke, M. F. Cancer stem cells, models and concepts. Annu. Rev. Med., 2007, 58, 267-284.
30. Lee, J. T.; Herlyn, M. Embryogenesis meet tumorigenesis. Nat. Med., 2006, 12, 882-883.
31. Katoh, M.; Katoh, M. Transcriptional regulation of WNT2B based on the balance of Hedgehog, Notch, BMP and WNT signals. Int. J. Oncol., 2009, 34(5), 1411-1415.
32. Kathoh, M.; Katoh M. Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades. Int. J. Mol. Med., 2009, 23 (6), 763-769.
33. Peifer, M.; Polakis, P. WNT signaling in oncogenesis and embryogenesis, a look outside the nucleus. Science, 2000, 287, 1606-1609.
34. Chritofk, H. F.; Vander Heiden, M. G.; Harris, M. H.; Ramanathan, A.; Gerszten, R. E.; Wei, R.; Fleming, M. D.; Schreiber, S. L.; Cantley, L. C. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumor growth. Nature, 2008, 452, 230-233.
35. Mani, S. A.; Guo, W.; Liao, M.; Eaton, E.; Ayyanan, A.; Zhou, A.; Brooks, M.; Reinhard, F.; Zhang, C.; Shipitsin, M. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell, 2008, 133, 704-715.
36. Carro, M. S.; Lim, W. K.; Javier Alvares, M.; Bollo, R. J.; Zhao, X.; Snyder, E. Y.; Sulman, E. P.; Anne, S. L.; Doetsch, F.; Colman, H.; Lasorella, A.; Adape, K.; Califano, A.; Iavarone, A. The transcriptional network for mesenchymal transformation of brain tumor. Nature, 2010, 463 (7279), 318-325.
37. Borczuk, A. C.; Gorenstein, L.; Walter, K. L.; Assaad, A. A.; Wang, L.; Powell, C. A. Non small-cell lung cancer molecular signature recapitulate lung developmental pathways. Am. J. Pathol., 2003, 163, 1949-1460.
38. Ben-Porath, I.; Thomson, M. W.; Carey, V. J.; Ge, R.; Bell, G. W.; Regev, A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet., 2008, 40, 499-507.
39. Biava, P. M.; Bonsignorio, D.; Hoxa, M. Cell proliferation curves of different human tumor lines after in vitro treatment with Zebrafish embryonic extracts. J. Tumor Marker Oncol., 2001, 16 195-202.
40. Biava, P. M.; Carluccio, A. Activation of anti-oncogene p53 produced by embryonic extracts in vitro tumor cells. J. Tumor Marker Oncol., 1977, 12, 9-15.
41. Biava, P. M.; Bonsignorio, D.; Hoxa, M.; Facco, R.; Ielapi, T.; Frati, L.; Bizzarri, M. Post-traslational modification of the retinoblastoma protein (pRb) induced by in vitro administration of Zebrafish embryonic extracts on human kidney adenocarcinomacell line. J. Tumor Marker Oncol., 2002, 17(2), 59-64.
42. Cucina, A.; Biava, P. M.; D'Anselmi, F.; Coluccia, P.; Conti, F.; Di Clemente, R.; Miccheli, A.; Frati, L.; Gulino, A.; Bizzarri, M. Zebrafish embryo proteins induce apoptosis in human colon cancer cells (Caco2). Apoptosis, 2006, 9, 1617-1628.
43. Livraghi, T.; Meloni, F.; Frosi, A.; Lazzaroni, S.; Bizzarri, M.; Frati, L.; Biava, P. M. Treatment with stem cell differentiation stage factors of intermediate-advanced hepatocellular carcinoma, an open randomized clinical trial. Oncol Res., 2005, 15 (7-8), 399-408.
44. Biava, P. M.; Bonsignorio, D. Cancer and cell differentiation, a model to explain malignancy. J. Tumor Marker Oncol., 2002, 17(3), 47-54.
45. Reya, T.; Morrison, S. J.; Clarke, M. F.; Weisman, I. L. Stem cells, cancer and cancer stem cells. Nature, 2001, 414(6859), 105-111.
46. Sato, A.; Sakurada, K.; Kumabe, T.; Sasajima, T.; Beppu, T.; Azano, K.; Ohkuma, H.; Ogawa, A.; Mizoi, K.; Tominaga, T.; Kitanaka, C.; Kayama, T. Association of stem cell marker CD133 expression with dissemination of glioblastoma. Neurosurg. Rev., 2010, 33(2), 175-183.
47. Di Tommaso, T.; Mazzoleni, S.; Wang, E.; Sovena, G.; Claverna, D.; Franzin, A.; Mortini, P.; Ferrone, S.; Doglioni, C.; Marincola, F. M.; Galli, R.; Parmiani, G.; Maccalli, M. Immunubiological characterization of cancer stem cells isolated from glioblastoma patients. Clin. Cancer Res., 2010, 16(3), 800-813.
48. Ji, J.; Black, K. C.; Yu, J. S. Glioma stem cell research for the development of immunotherapy. Neurosurg. Clin. N. Am., 2010, 21(1), 159-166.
49. Chen, J.; Chen, Z. L. Technology update for the sorting and identification of breast cancer stem cells. Chin. J. Cancer, 2010, 29 (3), 265-269.
50. Roesler, R.; Cornelio, D. B.; Abujama, A. L.; Schwartsmann, G. HER2 as a cancer stem-cell target. Lancet Oncol., 2010, 11(3), 225-226.
51. Wu, W. Patents related to cancer stem cell research. Recent Pat. DNA Gene Seq., 2010, 4(1), 40-45.
52. Park, S. Y.; Lee, H. E.; Li, H.; Shipitsin, M.; Gelman, R.; Polyak, K. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Cancer Res., 2010, 16(3), 876-887.
53. Lawson, J. C.; Blatch, G. L.; Edkins, A. L. Cancer stem cells in breast cancer and metastasis. Cancer Res. Treat., 2009, 8(2), 241-254.
54. Luo, J.; Yin, X.; Ma, T.; Lu, J. Stem cells in normal mammary gland and breast cancer. Am. J. Med. Sci., 2010, 339(4), 366-370.
55. Spiro, S. G.; Tanner, N. T.; Silvestri, G. A.; James, S. M.; Lim, E.; Vansteenkiste, J. F.; Pirker, R. Lung cancer, progress in diagnosis staging and therapy. Respirology, 2010, 15(1), 44-50.
56. Gorelik, E.; Lokshin, A.; Levina, L. Lung cancer stem cells as target for therapy. Anticancer Agents Med. Chem., 2010, 10(2), 164-171.
57. Sullivan, J. P.; Minna, J. D.; Shay, J. W. Evidence for selfrenewing lung cancer stem cells and their implications in tumor initiation, progression and targeted therapy. Cancer Metastasis Rev., 2010, 29(1), 61-72.
58. Westhoff, B.; Colaluca, I. N.; D'Ario, G.; Donzelli, M.; Tosoni, D.; Volorio, G.; Pelosi, G.; Spaggiari, L.; Mazzarol, G.; Viale, G.; Pece, S.; Di Fiore, P. P. Alteration of the Notch pathway in lung cancer. Proc. Natl. Acad. Sci. USA, 2010, 87(3), 457-466.
59. Lawson, D. A.; Zong, Y.; Memarzadeh, S.; Xin, L.; Huang, J.; Witte, O. N. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc. Natl. Acad. Sci. USA, 2010, 107(6), 2610-2615.
60. Lang, S. H.; Anderson, E.; Fordham, R.; Collin, A. T. Modeling the prostate stem cell niche, an evaluation of stem cell survival and expansion in vitro. Stem Cells Rev., 2010, 19(4), 537-546.
61. Joung, J. Y.; Cho, K. S.; Kim, J. E.; Seo, H. K.; Ching, J.; Park, W. S.; Choi, M. K.; Lee, K. H. Prostate stem cell antigen mRNA in peripheral blood as a potential predictor of biochemical recurrence of metastatic prostate cancer. J. Surg. Oncol., 2010, 101(2), 145-148.
62. Liu, T.; Cheng, W.; Lai, D.; Huang, Y.; Guo, L. Characterization of primary ovarian cancer cells in different culture systems. Oncol. Rep., 2010, 23(5), 1277-1284.
63. Fong, M. Y.; Kakar, S. S. The role of cancer stem cells the side population in epithelial ovarian cancer. Histol. Histopathol., 2010, 25(1), 113-120.
64. Murphy, S. K. Targeting ovarian cancer initiating cells. Anticancer Agents, 2010, 10(2), 157-163.
65. Pen, S.; Maihle, N. J.; Huang, Y. Pluripotency facrors Lin 28 and Oct 4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene, 2010, 29(14), 2153-2159.
66. Kusumbe, A. P.; Bapat, S. A. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res., 2009, 69(24), 9245-9253.
67. Tomuleasa, C.; Soritau, O.; Rus-Ciuca, D.; Pop, T.; Todea, D.; Mosteanu, O.; Pintea, B.; Foris, V.; Susman, S.; Kacso, G.; Irimie, A. Isolation and characterization of hepatic cells with stem-like properties from hepatocellular carcinoma. J. Gastrointestin. Liver Dis., 2010, 19(1), 61-67.
68. Zou, G. M. Liver cancer stem cells as an important target in liver cancer therapies. Anticancer Agents Med. Chem., 2010, 10(2), 172-175.
69. Lee, T. K.; Castilho, A.; Ma S.; Ng, I.O. I. Liver cancer stem cells, implication for new therapeutic target. Liver Intern., 2009, 29(5), 955-965.
70. Marquardt, J. U.; Thorgeirsson, S. S. Stem cells in hepatocarcinogenesis, evidence from genomic data. Semin Liver Dis., 2010, 30(1), 26-34.
71. Kung, J. W.; Currie, I. S.; Forbes, S. J.; Ross, J. A. Liver development, regeneration, and carcinogenesis. J. Biomed. Biotechnol., 2010, 30(1), 26-34.
72. Gai, H.; Nguyen, D. M.; Moon, Y. J.; Aguila, J. R.; Fink, L. M.; Ward, D. C.; Ma, Y. Generation of murine hepatic lineage cells from induced pluripotent stem cells. Differentiation, 2010, 79(3), 171-181.
73. Correia, M.; Machado, J. C.; Ristimaki, A. Basic aspects of gastric cancer. Helicobacter, 2009, 14(1), 36-40.
74. Takaishi, S.; Okumura, T.; Tu, S.; Wang, S. S.; Shibata, W.; Vigneshwaran, R.; Gordon, S.A.; Shimada, Y.; Wang, T. C. Identification of gastric cancer stem cells using the surface marker CD44. Stem Cells, 2009, 59(5), 106-120.
75. Nishii, T.; Yashiro, M.; Shinto, O.; Sawada, T.; Ohira, M.; Hirakawa, K. Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Sci., 2009, 100(8), 1397-1402.
76. Chen, Z.; Xu, W. R.; Quian, H.; Zhu, W.; Bu, X. F.; Wang, S.; Yan, Y. M.; Mao, F.; Gu, H. B.; Cao, H. L.; Xu, X. J. Oct4 a novel marker for human gastric cancer. J. Surg. Oncol., 2009, 34(5), 1201-1207.
77. Kang, D. H.; Han, M. E.; Song, M. H.; Lee, Y. S.; Kim, E. H.; Kim, H. J.; Kim, G. H.; Kim, D. H.; Yoon, S.; Baek, S. Y.; Kim, B. S.; Kim, G. B.; Oh, S. O. The role of hedgehog signaling during gastric regeneration. J. Gastroenterol., 2009, 44(5), 372-379.
78. Yeung, T. M.; Ghandhi, S. C.; Wilding, J. L.; Muschel, R.; Bodmer, W. F. Cancer stem cells from colorectal cancer derived cell lines. Proc. Natl. Acad. Sci. USA, 2010, 107(8), 3722-3727.
79. Gulino, A.; Ferretti, E.; De Smaele, E. Hedgehog signaling in colon cancer and stem cells. EMBO, 2009, 1(6-7), 300-302.
80. Thenappen, A.; Li, Y.; Shetty, K.; Johnson, L.; Reddy, E. P.; Mishra, L. New therapeutic targeting colon cancer stem cells. Curr. Colorectal Cancer Rep., 2009, 5(4), 209.
81. Rasheed, Z. A.; Yang, J.; Wang, Q.; Kowalski, J.; Freed, I.; Murter, C.; Hong S. M.; Koorstra, J. B.; Rajeshkumar, N. V.; He, X.; Goggins, M.; Iacobuzio-Donahue, C.; Berman, D. M.; Laheru, D.; Jimeno, A.; Hidalgo, M.; Maitra, A.; Matsui, W. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J. Natl. Cancer Inst., 2010, 102(5), 340-351.
82. Puri, S.; Hebrok, J. Cellular plasticity within pancreas-lessons learned from development. Dev. Cell, 2010, 18(3), 342-356.
83. Quante, M.; Wang, T. C.; Stem cells in gastroenterology and hepatology. Nat. Rev. Gastroenterol. Hepatol., 2009, 6(12), 724-737.
84. Ailles, L.; Prince, M. Cancer stem cells in head and neck squamous cell carcinoma. Methods Mol. Biol., 2009, 568, 175-193.
85. Zhang, P.; Zhang, Y.; Mao, L.; Zhang, Z.; Chen, W. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotype. Cancer Lett., 2009, 277(2), 227-234.
86. Brunner, M.; Thurnher, D.; Heiduschka, G.; Grasl, M. C. h.; Brostjan, C.; Erovic, B. M. Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients. J. Surg. Oncol., 2008, 98(7), 545-550.
87. Zhang, Q.; Shi, S.; Yen, Y.; Brown, J.; Ta, J.Q.; Le, A. D. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett., 2010, 289(29), 151-160.
88. Tesfatsion, L.; Judd, K. Handbook of Computational Economics; Elsevier: Amsterdam (NL), 2006, Vol. 2.
89. Myrskylä, M.; Kohler, H. P.; Billari, F. C. Advances in development reverse fertility declines, Nature, 2009, 460, 741-743.
90. Farmer, J. D.; Foley, D. The economy needs agent-based modeling. Nature, 2009, 460, 685-686.
91. Bankes, S. C. Agent-based modeling, A revolution? Proc. Natl. Acad. Sci. USA, 2002, 99, 7199-7200.
92. Chou, K. C. Curr. Structural bioinformatics and its impact to biomedical science. Med. Chem., 2004, 11, 2105-2134.
93. Bandini, S.; Manzoni, S.; Vizzari, G. Agent based modeling and simulation, an informatics perspective. http,//jasss.soc.surrey.ac.uk/12/4/4.html, 2009.
94. Kauffman, S.A. The Origins of Order; Oxford UP: N Y, 1993.
95. Michel, F.; Ferber, J.; Drogoul, A. In: Multi-Agent Systems and Simulation, a Survey From The Agent Community's Perspective; Uhrmacher, A. M.; Weyns, D. Eds.; Multi-agent systems, simulation and applications. Taylor & Francis: N Y, 2009, pp. 3-52.
96. Troitzsch, K. G. In: Multi-Agent Systems and Simulation, A Survey from an Application Perspective; Uhrmacher, A. M.; Weyns, D. Eds., Multi-agent systems, simulation and applications. Taylor & Francis, N Y, 2009, pp. 53-76.
97. Chen, L. L.; Zhang, L.; Yoon, Y.; Deisbroeck, T. Cancer cell motility, Optimizing spatial search strategies. BioSystems, 2009, 95, 234-242.
98. Chen, L. L.; Blumm, N.; Christakis, N. A.; Barabasi, A. L.; Deisboeck, T. S. Cancer metastasis networks and the prediction of progression patterns. Br. J. Cancer, 2009, 101, 749-758.
99. Loscalzo, J.; Kohane, I.; Barabasi, A. L. Human disease classification in the postgenomic era, A complex systems approach to human pathobiology. Mol. Syst. Biol., 2007, 3, 124.
100. Vogelstein, B.; Lane, D.; Levine, A. J. Surfing the p53 network. Nature, 2000, 408, 307-310.
101. Datta, A.; Choudhary, A.; Bittner, M. L.; Dougherty, E. R. Modeling and control in cancer genomics, Ioannou, P.A.; Pitsillides, A., Eds.; In: Modeling and Control of Complex Systems; Taylor & Francis: NY, 2008, pp. 339-366.
102. Huang, S.; Ernberg, I.; Kauffman, S.A. Cancer attractors, a systems view of tumors from a gene network dynamics and developmental perspective. Semin. Cell Dev. Biol., 2009, 20, 869-876.
103. Gilbert, N. Agent-based Models; Sage: London, 2008.
104. Edmonds, B.; Moss, S. J. In: From KISS to KIDS, an "Anti- Simplistic" Modelling Approach; Davidsson, P., Eds.; Multi-Agent Based Simulation. Springer: Berlin, 2004, pp. 130-144.
105. Walker, D.; Wood, S.; Southgate, J.; Holcombe, M.; Smallwood, R. An integrated agent-mathematical model of the effect of intercellular signalling via the epidermal growth factor receptor on cell proliferation. J. Theor. Boil., 2006, 242, 774-789.
106. An, G. Introduction of an agent-based multi-scale modular architecture for dynamic knowledge representation of acute inflammation. Theor. Biol. Med. Model., 2008, 5(11), 1-20.
107. Ren, L. H.; Ding, Y. S.; Shen, Y. Z.; Zhang, X. F. Multi-agentbased bio-network for systems biology, protein-protein interaction network as an example. Amino Acids, 2008, 35, 565-572.
108. Pogson, M.; Smallwood, R.; Qwarnstrom, E.; Holcombe, M. Formal agent-based modelling of intracellular chemical interactions. Biosystems, 2006, 85, 37-45.
109. Baldazzi, V.; Castiglione, F.; Bernaschi, M. An enhanced agent based model of the immune system response. Cell. Immunol., 2006, 244(2), 77-79.
110. Bernaschi, M.; Castiglione, F. Design and implementation of an immune system simulator. Comput. Biol. Med., 2001, 31, 303-331.
111. Castiglione, F.; Liso, A.; Bernaschi, M.; Succi, S. Microscopic simulation in biology and medicine. Curr. Med. Chem., 2007, 14, 625-637.
112. Celada, F.; Seiden, P. E. A computer model of cellular interactions in the immune system. Immunol. Today, 1992, 13, 56-62.
113. Folcik, V. A.; An, G. C.; Orosz, C. G. The basic immune simulator, an agent-based model to study the interactions between innate and adaptive immunity. J. Theor. Biol., 2007, 4, 39-52.
114. Forrest, S.; Beauchemin, C. Computer immunology. Immunol. Rev., 2007, 216, 176-197.
115. Gonzàles, P.; Càrdenas, M.; Camacho, D.; Franyuti, A.; Rosas, O.; Lagùnez-Otero, J. Cellutat, an agent-based intracellular signaling model. Biosystems, 2003, 68, 171-185.
116. Kleinstein, S. H.; Seiden, P. E. Simulating the immune system. Comp. Sci. Eng., 2000, 2, 69-77.
117. Meyer-Schellersheim, M.; Mack, G. SIMMUNE, a tool for simulating and analyzing immune system behavior. http,//aexiv.org/abs/cs/9903017v1, 1999.
118. Seiden, P. E.; Celada, F. A model simulating cognate recognition and response in the immune system. J. Theor. Biol., 1992, 158, 329-357.
119. Warrender, C.E. CyCells simulator. http,//sourceforge.net/projects/cycells, 2005.
120. Yates, A.; Chan, C. C. W.; Callard, R. E.; George, A. J. T.; Stark, Y. An approach to modelling in immunology. Brief. Bioinformatics, 2001, 2(3), 245-257.
121. Cheng, Y.; Ghersi, D.; Calcagno, C.; Selin, L. K.; Puzone, R.; Celada, F. A discrete computer model of the immune system reveals competitive interactions between the humoral and cellular branch and between cross-reacting memory and naive responses. Vaccine, 2009, 27, 833-845.
122. Meyer-Hermann, M. A concerted action of B cell selection mechanisms. Adv. Complex Syst., 2007, 10(4), 557-580.
123. Kohler, B.; Puzone, R.; Seiden, P. E.; Celada, F. A systematic approach to vaccine complexity using an automaton model of the cellular and humoral immune system. Vaccine, 2000, 19, 862-876.
124. Celada, F.; Seiden, P. E. Affinity maturation and hypermutation in a simulation of the humoral immune response. Eur. J. Immunol., 1996, 26, 1350-1358.
125. Bernaschi, M.; Castiglione, F. Selection of escape mutants from immune recognition during HIV infection. Immunol. Cell. Biol., 2002, 80, 307-313.
126. Mansury, Y.; Kimura, M.; Lobo, J.; Deisboeck, T. S. Emerging pattern in tumor systems, simulating the complex dynamics of multicellular cluster structures by using a novel agent-based spatiotemporal agglomeration model. J. Theor. Biol., 2002, 219, 343-370.
127. Zhang, L.; Chaitanya, A. A.; Deisboeck, T. S. Development of a three-dimensional multiscale agent-based tumor model, Simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J. Theor. Biol., 2007, 244, 96-107.
128. Zhang, L.; Wang, Z.; Sagotsky, J. A. Deisbroeck, T.S. Multiscale agent-based cancer modeling. J. Math. Biol., 2009, 58, 545-559.
129. Bonabeau, E. Agent-based modeling, methods and techniques for simulating human systems. Proc. Natl. Acad. Sci. USA, 2002, 99(3), 7280-7287.
130. Desmeulles, G.; Querrec, G.; Redou, P.; Kerdèlo, S.; Misery, L.; Rodin, V.; Tisseau, J. The virtual reality applied to biology understanding, The in virtuo experimentation. Expert Syst. Appl., 2006, 30, 82-92.
131. Theodoropoulos, G. K.; Minson, R.; Ewald, R.; Lees, M. Simulation engines for multi-agent systems, Uhrmacher, A. M.; Weyns, D., Eds.; In: Multi-Agent Systems, Simulation and Applications; Taylor & Francis: N Y, 2009, pp. 77-108.
132. d'Inverno, M.; Howells, P.; Montagna, S.; Roeder, I.; Saunders, R. Agent-Based Modelling of Stem Cells, Uhrmacher, A. M.; Weyns, D. Eds.; In: Multi-Agent Systems, Simulation and Application; Taylor & Francis: NY, 2009, pp. 389-423.